Strategy

Dodd-Frank: What's Relevant for Boards of Public Companies
Deloitte - Aug 31, 2011
A recent publication by Deloitte's Center For Corporate Governance, The Dodd-Frank Act's impact on public companies: After one year, provides an update on provisions that may be applicable to all public companies - those now final, those in proposal stage, and those under consideration. Read more about the provisions of the Dodd-Frank Act that are of importance and relevance to the board of directors.

The Top 11 Hot Topics for Directors in 2011
Deloitte - Jan 20, 2011
This edition provides insights on boardroom priorities and key issues in the context of today’s challenging business environment. To see expanded discussion on these topics developed by Deloitte Touche Tohmatsu member firms, as well as questions that directors may ask related to each topic, see Directors’ Alert: 11 Issues for 2011

Good Medicine or a Bitter Pill? Health Care Reform
Deloitte - Oct 31, 2010
The full implications of the Patient Protection and Affordable Care Act, and other legislative and regulatory initiatives affecting health care, will unfold over the next decade and beyond. But the journey to a new health care system has begun, with enormous implications for American businesses.

Merger & Acquisition Valuation: The New Normal CFO Insights
Deloitte - Oct 07, 2010
As companies turn toward M&A to accelerate growth, boards and management have the same ultimate goal: value creation. Both want to realize financial and other outcomes from the deals they pursue and want to have high confidence in realizing the outcomes without undue risk. This is creating a “new normal” for deal valuation and pre-transaction planning and modeling. Recognizing the change in practices and establishing capabilities for providing clearer perspectives and detailed analysis of prospective transactions can position CFOs to advance future transactions more effectively and with greater confidence.

Strategies for Going Public
Deloitte - Mar 10, 2010
You may be thinking of taking your company public and, if so, you undoubtedly have many questions. Deloitte has been advising clients and assisting them in the process of going public for many years. Drawing on that experience, we have prepared this publication to assist you in answering those questions, to acquaint you with the “language” of going public, and to give you a working knowledge of some of the technicalities of the process.

Planning for Success: 10 Steps to Take Before the IPO Window Opens
Sharon Merrill Associates - Mar 19, 2009
Forecasts vary as to when the IPO market will come back, and even optimists say it could take a long time. To give you a sense of how slow the market has been, there were only 43 IPOs priced in 2008 versus 272 in the prior year. In your role as director of a pre-IPO company,it is your responsibility to ensure that management is using the current slowdown in the market to the company’s advantage. It is also an opportunity to update your own knowledge about recent developments in corporate disclosure and investor relations. Directors are increasingly becoming involved in these areas at the tactical, as well as strategic, levels.

How Effective Is Your Board?
Egon Zehnder International - Sep 20, 2008

Views and advice expressed in the Topic Library area of this web site do not necessarily represent those of NACD and should not be construed as legal or professional advice.

If you have additional topics you would like to see on this site please let us know.